BPG is committed to discovery and dissemination of knowledge
Welcome to the World Journal of Gastrointestinal Oncology

The World Journal of Gastrointestinal Oncology (WJGO) is a leading academic journal devoted to reporting the latest, cutting-edge research progress and findings of basic research and clinical practice in the field of gastrointestinal oncology.  It was launched on October 15, 2009 and is published monthly (12 issues annually) by BPG, the world's leading professional clinical medical journal publishing company.

We encourage gastrointestinal oncologists worldwide to submit manuscripts to the WJGO describing their original basic or clinical research findings that are of high academic value and which report new diagnostic techniques or summarize their treatment experiences.

The usual times related to all publication processes of the WJGO are as follows: (1) From manuscript receipt to peer-review: 2-4 weeks; (2) From initial manuscript acceptance, with revisions, to return of the revised manuscript from the authors: 4-5 weeks; (3) From return of the revised manuscript from the authors to final acceptance: 1-2 weeks; (4) From final acceptance to an article in press: 2 days; and (5) From article in press designation to formal release of the electronic version and all online documentation: 2-9 weeks. The WJGO’s acceptance rate: 46%.  Submit here >>

2017 Published Issues
4 3 2 1

Hsin-Chen Lee, PhD, Professor; DH Roukos, MD,PhD, Professor


PubMed, PubMed Central, Science Citation Index Expanded (also known as SciSearch®), and Journal Citation Reports/Science Edition.

Journal Metrics

There is currently no impact factor.


1948-5204 (online)

Abnormal DNA methylation as a cell-free circulating DNA biomarker for colorectal cancer detection: A review of literature  
Michail Galanopoulos, Nikolaos Tsoukalas, Ioannis S Papanikolaou, Maria Tolia, Maria Gazouli, Gerassimos J Mantzaris
World J Gastrointest Oncol 9(4):142-152. Published online Apr 15, 2017. doi: 10.4251/wjgo.v9.i4.142
Basic Study
Effect of Clostridium perfringens enterotoxin on gastric cancer cells SGC7901 which highly expressed claudin-4 protein  
Zheng-Yun Liang, Xing Kang, Hong Chen, Meng Wang, Wen-Xian Guan
World J Gastrointest Oncol 9(4):153-159. Published online Apr 15, 2017. doi: 10.4251/wjgo.v9.i4.153
Observational Study
Bayesian adjustment of gastric cancer mortality rate in the presence of misclassification  
Nastaran Hajizadeh, Mohamad Amin Pourhoseingholi, Ahmad Reza Baghestani, Alireza Abadi, Mohammad Reza Zali
World J Gastrointest Oncol 9(4):160-165. Published online Apr 15, 2017. doi: 10.4251/wjgo.v9.i4.160
Macroscopic appearance of Type IV and giant Type III is a high risk for a poor prognosis in pathological stage II/III advanced gastric cancer with postoperative adjuvant chemotherapy  
Keishi Yamashita, Akira Ema, Kei Hosoda, Hiroaki Mieno, Hiromitsu Moriya, Natsuya Katada, Masahiko Watanabe
World J Gastrointest Oncol 9(4):166-175. Published online Apr 15, 2017. doi: 10.4251/wjgo.v9.i4.166
Prospective Study
Incidence of venous thromboembolism and the role of D-dimer as predictive marker in patients with advanced gastric cancer receiving chemotherapy: A prospective study  
Kwonoh Park, Baek-Yeol Ryoo, Min-Hee Ryu, Sook Ryun Park, Myoung Joo Kang, Jeong Hye Kim, Seungbong Han, Yoon-Koo Kang
World J Gastrointest Oncol 9(4):176-183. Published online Apr 15, 2017. doi: 10.4251/wjgo.v9.i4.176
Helicobacter pylori recurrence after eradication in Latin America: Implications for gastric cancer prevention  
Juan E Corral, Robertino Mera, Corey W Dye, Douglas R Morgan
World J Gastrointest Oncol 9(4):184-193. Published online Apr 15, 2017. doi: 10.4251/wjgo.v9.i4.184